These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1741800)

  • 1. Propofol does not trigger malignant hyperthermia.
    Gallen JS
    Anesth Analg; 1991 Mar; 72(3):413-4. PubMed ID: 1741800
    [No Abstract]   [Full Text] [Related]  

  • 2. Propofol and malignant hyperthermia.
    Kumata DS
    Anesth Analg; 1992 Feb; 74(2):318. PubMed ID: 1590832
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal side-effects of continuous propofol infusion in children may be related to malignant hyperthermia.
    Plötz FB; Waalkens HJ; Verkade HJ; Strengers JL; Knoester H; Mandema JM
    Anaesth Intensive Care; 1996 Dec; 24(6):724. PubMed ID: 8971326
    [No Abstract]   [Full Text] [Related]  

  • 4. Propofol and malignant hyperthermia susceptibility.
    Pollock AN; McKenzie AJ; Hodges M; Snoeck MM
    Anaesth Intensive Care; 1997 Oct; 25(5):583-5. PubMed ID: 9352778
    [No Abstract]   [Full Text] [Related]  

  • 5. [Propofol triggers a marked body temperature increase in a patient with fulminant malignant hyperthermia (MH) without inducing other symptoms of MH].
    Murao K; Umegaki T; Masuzawa M; Inoue S; Nakao S; Shingu K
    Masui; 2010 Jan; 59(1):92-6. PubMed ID: 20077777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of propofol on the malignant hyperthermia susceptible pig model.
    Krivosic-Horber R; Reyfort H; Becq MC; Adnet P
    Br J Anaesth; 1989 Jun; 62(6):691-3. PubMed ID: 2787665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal outcome after propofol sedation in children.
    Plötz FB; Waalkens HJ; Verkade HJ
    Anaesth Intensive Care; 1997 Oct; 25(5):585. PubMed ID: 9352779
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of propofol on Ca2+ regulation by malignant hyperthermia-susceptible muscle membranes.
    Fruen BR; Mickelson JR; Roghair TJ; Litterer LA; Louis CF
    Anesthesiology; 1995 May; 82(5):1274-82. PubMed ID: 7741303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal outcome after propofol sedation in children.
    Neff SP; Futter ME; Anderson BJ
    Anaesth Intensive Care; 1997 Oct; 25(5):581-3. PubMed ID: 9352777
    [No Abstract]   [Full Text] [Related]  

  • 10. Propofol for anesthesia in a patient susceptible to malignant hyperthermia.
    Rosenberg MB
    Anesth Prog; 1991; 38(3):96-8. PubMed ID: 1839946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol and malignant hyperpyrexia.
    Denborough M; Hopkinson KC
    Lancet; 1988 Jan; 1(8578):191. PubMed ID: 2893036
    [No Abstract]   [Full Text] [Related]  

  • 12. Propofol and malignant hyperthermia.
    Allen G
    Anesth Analg; 1991 Sep; 73(3):359. PubMed ID: 1867435
    [No Abstract]   [Full Text] [Related]  

  • 13. Propofol-induced changes in myoplasmic calcium concentrations in cultured human skeletal muscles from RYR1 mutation carriers.
    Migita T; Mukaida K; Kawamoto M; Kobayashi M; Nishino I; Yuget O
    Anaesth Intensive Care; 2007 Dec; 35(6):894-8. PubMed ID: 18084979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol anesthesia in the malignant hyperthermia susceptible patient.
    Klotz RW
    Nurse Anesth; 1991 Mar; 2(1):33-5. PubMed ID: 2021658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overheating alone can trigger malignant hyperthermia in piglets.
    Denborough M; Hopkinson KC; O'Brien RO; Foster PS
    Anaesth Intensive Care; 1996 Jun; 24(3):348-54. PubMed ID: 8805890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthesia and mitochondrial disorders.
    Schwartz D; Raghunathan K
    Paediatr Anaesth; 2009 Jan; 19(1):60-1. PubMed ID: 19076514
    [No Abstract]   [Full Text] [Related]  

  • 17. The screening of propofol in MHS swine.
    Raff M; Harrison GG
    Anesth Analg; 1989 Jun; 68(6):750-1. PubMed ID: 2786680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of propofol in a female patient predisposed to malignant hyperthermia (central core disease)].
    Rivolta M; Riedo R; Ostaldo M; Fontana G; Motta F
    Minerva Anestesiol; 1992 Apr; 58(4):219-21. PubMed ID: 1620420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of high dose administration of propofol].
    Nishioka H; Kinuwaki H; Shimoda O; Terasaki H
    Masui; 2000 Oct; 49(10):1142-4. PubMed ID: 11075566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No response to trigger agents in a malignant hyperthermia-susceptible patient.
    Claxton BA; Cross MH; Hopkins PM
    Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.